JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
27/10/22 - 13:44
Revenue growth and strong profitability in the first 9 months of 2022 - Full year 2022 Guidance revised upwards (316.32 KB)
03/08/22 - 12:26
Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards (316.69 KB)
06/05/22 - 16:45
Strong growth in revenues and cash flow generation in Q1 2022 - Full Year 2022 Guidance revised upwards (467.24 KB)
16/03/22 - 17:39
DiaSorin business momentum and the Luminex acquisition drive up revenues, net result and cash flow generation in 2021 (404.69 KB)
14/11/14 - 1:00
The Board of Directors approves the results for Q3'14 (785.42 KB)
01/08/14 - 2:00
The Board of Directors approves the results for H1'14 (812.25 KB)
22/07/14 - 2:00
DIASORIN CONFIRMS ITS ELIGIBILITY FOR THE PEA-PME (148.49 KB)
09/05/14 - 2:00
The Board of Directors approves the results for Q1'14 (573.05 KB)
23/04/14 - 2:00
Shareholders' meeting approves FY Results 2013 (107.65 KB)
06/03/14 - 1:00